At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Press Releases

Press Releases

All Releases
View Summary Amicus Therapeutics to Announce Second Quarter 2015 Financial Results on August 5, 2015
Jul 29, 2015
PDF 19.8 KB
View Summary Amicus Therapeutics Joins Russell 3000(R) and Russell 2000(R) Indexes
Jun 29, 2015
PDF 19.5 KB
View Summary Amicus Therapeutics Announces Galafold(TM) Marketing Authorization Application (MAA) Validated by European Medicines Agency (EMA)
Jun 25, 2015
PDF 23.6 KB
View Summary Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option
Jun 17, 2015
PDF 17.8 KB
View Summary Amicus Therapeutics Prices Underwritten Offering of Common Stock
Jun 11, 2015
PDF 21.6 KB
View Summary Amicus Therapeutics Announces Public Offering of Common Stock
Jun 10, 2015
PDF 22.8 KB
View Summary Amicus Therapeutics Strengthens Executive Leadership Team
Jun 8, 2015
PDF 25.3 KB
View Summary Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union
Jun 3, 2015
PDF 27.3 KB
View Summary Amicus Therapeutics' Fabry Monotherapy Granted Accelerated Assessment by European Regulators
May 26, 2015
PDF 23.6 KB
View Summary Amicus Therapeutics Announces First Quarter 2015 Financial Results and Corporate Updates
May 5, 2015
PDF 31.1 KB
View Summary Amicus Therapeutics to Announce First Quarter 2015 Financial Results on May 5, 2015
May 1, 2015
PDF 16.1 KB
View Summary Amicus Therapeutics Appoints David Allsop as Senior Vice President, International
Apr 27, 2015
PDF 20.4 KB
View Summary Amicus Therapeutics Honors Fabry Disease Awareness Month and International Pompe Day
Apr 9, 2015
PDF 22.5 KB
View Summary Amicus Therapeutics Provides Positive Global Regulatory Updates From EMA and FDA Meetings for Fabry Monotherapy
Mar 19, 2015
PDF 32.0 KB
View Summary Amicus Therapeutics Announces Full-Year 2014 Financial Results and Corporate Updates
Mar 3, 2015
PDF 33.0 KB
View Summary Amicus Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference
Feb 26, 2015
PDF 16.1 KB
View Summary Amicus Therapeutics to Announce Full-Year 2014 Financial Results on March 3, 2015
Feb 25, 2015
PDF 16.2 KB
View Summary Amicus Therapeutics Announces Additional Positive Phase 3 Fabry Data on Patient Reported Outcomes at WORLDSymposium(TM) 2015
Feb 10, 2015
PDF 28.4 KB
View Summary Amicus Therapeutics Presents Preclinical Data on Next-Generation Pompe ERT at WORLDSymposium(TM) 2015
Feb 10, 2015
PDF 21.5 KB
View Summary Amicus Therapeutics to Present at Leerink Global Healthcare Conference
Feb 4, 2015
PDF 16.0 KB
Showing 1-20 of 253 Page: 1 2 3 4 5 ... 13  Next 20

Copyright © 2015 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy